US 8637560
Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment
granted A61KA61K31/4166A61K31/4178
Quick answer
US patent 8637560 (Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4166, A61K31/4178, A61P, A61P31/12